Publication | Closed Access

Addition of sitagliptin to ongoing glimepiride therapy in Japanese patients with type 2 diabetes over 52 weeks leads to improved glycemic control

Metabolic SyndromeDiabetes ManagementCardiovascular DiseaseHealth PolicyGlimepiride TherapyGlobal HealthDiabetesType 2Diabetes MellitusPublic HealthMedicineJapanese Patients